-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Assessing the association between Alzheimer's disease risk factors and early pathological changes will help reveal the potential of early intervention and preventive measures for Alzheimer's disease
Preventing to determine whether the risk factors of Alzheimer's disease clinical syndrome (clinical AD), such as body mass index (BMI), are related to Aβ misfolding in the blood (an important indicator of the risk of AD in the elderly)
The ESTHER study is a population-based cohort study of German elderly (50-75 years old) that collected information about risk factors and blood samples from subjects at baseline
immunity
(A) BMI changes in subjects with or without Aβ misfolding; (B) BMI changes in subjects with or without clinical AD
(A) BMI changes in subjects with or without Aβ misfolding; (B) BMI changes in subjects with or without clinical ADAccording to the reported historical weight, BMI at age 50 was negatively correlated with Aβ misfolding (aOR 0.
BMI at 50 years old was negatively correlated with Aβ misfolding (aOR 0.
Original source:
Original source:Möllers Tobias, Stocker Hannah, Perna Laura et al.
Aβ misfolding in blood plasma is inversely associated with body mass index even in middle adulthood
in this message